| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| osimertinib mechanism of action review | 1.52 | 0.9 | 885 | 61 | 38 |
| osimertinib | 1.05 | 0.7 | 8366 | 7 | 11 |
| mechanism | 1.41 | 0.5 | 1867 | 69 | 9 |
| of | 1.36 | 0.1 | 795 | 54 | 2 |
| action | 1.86 | 0.8 | 3183 | 99 | 6 |
| review | 0.52 | 0.6 | 4471 | 99 | 6 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| osimertinib mechanism of action review | 1.5 | 0.7 | 1257 | 71 |
| osimertinib mechanism of resistance | 0.49 | 0.6 | 8236 | 14 |
| osimertinib duration of action | 1.88 | 0.7 | 3995 | 17 |
| resistance mechanisms to osimertinib | 0.32 | 0.2 | 6521 | 43 |
| how does osimertinib work | 0.92 | 0.3 | 7133 | 13 |
| osimertinib time to response | 1.28 | 0.4 | 971 | 49 |
| osimertinib summary basis of approval | 0.18 | 0.8 | 8079 | 58 |
| osimertinib mecanismo de accion | 1.2 | 0.2 | 449 | 68 |
| is osimertinib an immunosuppressant | 1.09 | 0.8 | 66 | 13 |
| primary resistance to osimertinib | 1.6 | 0.9 | 8478 | 82 |
| osimertinib + savolitinib | 0.79 | 1 | 464 | 69 |
| is osimertinib a chemotherapy drug | 1.63 | 1 | 4880 | 83 |
| what is osimertinib used for | 0.11 | 0.1 | 7467 | 20 |
| is osimertinib a chemotherapy | 1.24 | 1 | 6922 | 87 |
| osimertinib plasma protein binding | 1.86 | 0.4 | 1673 | 22 |
| osimertinib potential side effect | 0.1 | 0.4 | 3101 | 1 |
| osimertinib side effects macmillan | 0.11 | 0.5 | 3673 | 29 |
| osimertinib for breast cancer | 1.55 | 0.7 | 4902 | 22 |
| osimertinib_1919 | 0.23 | 0.3 | 9633 | 75 |
